Loading organizations...
§ Venture Capital · Toronto, Canada
This VC firm invests in biopharmaceuticals, healthcare platforms, and tech, focusing on removing barriers for promising companies across North America.
Built on strength and balance, Sixty Degree Capital invests in the evolving areas of biopharmaceuticals, healthcare platforms and technology. Engaging with companies throughout North America, we aim to remove the barriers between us and our potential in order to make present visions a reality.
Key people at Sixty Degree Capital.
Sixty Degree Capital is a venture capital firm focused on investing in biopharmaceuticals, healthcare platforms, and technology sectors across North America. Their mission is to accelerate the growth of high-potential companies by combining deep industry expertise, a robust global network, and a commitment to innovation. They invest from early stages (pre-seed) through growth, backing visionary founders who are building transformative companies that can reshape industries, particularly in healthcare (drug development, diagnostics, digital health, medical devices) and technology (AI, cybersecurity, digital infrastructure, SaaS)[1][3][4].
Founded in 2017 in Toronto, Canada, Sixty Degree Capital was established with a vision to invest in high-growth innovation globally while leveraging Canadian roots to connect local talent with global opportunities. The firm has evolved to maintain a thesis-driven investment approach, focusing on sectors where they can add meaningful insight and operational support. Their team blends academic excellence with industry experience, enabling them to provide strategic guidance and capital flexibility to portfolio companies[3][4].
Sixty Degree Capital rides the wave of rapid innovation in healthcare and technology, particularly in areas like AI, digital health, and biopharmaceuticals, which are transforming patient care and enterprise software. The timing is favorable due to increasing demand for advanced healthcare solutions and digital infrastructure, alongside growing investor interest in these sectors. By supporting companies that remove barriers to innovation, Sixty Degree Capital helps accelerate industry transformation and fosters a more connected, efficient startup ecosystem across North America and beyond[1][3].
Looking ahead, Sixty Degree Capital is poised to deepen its influence by continuing to back breakthrough innovations at the intersection of healthcare and technology. Trends such as AI-driven drug discovery, personalized medicine, and cloud-based enterprise solutions will likely shape their investment focus. Their ability to combine capital with domain expertise and a global network positions them to remain a key player in scaling transformative companies that deliver meaningful impact across industries[1][3].
In summary, Sixty Degree Capital stands out as a forward-thinking VC firm dedicated to removing barriers for promising companies by leveraging expertise, capital, and a global network to accelerate innovation in healthcare and technology.
Key people at Sixty Degree Capital.
Sixty Degree Capital has 26 tracked investments across 24 companies. The latest tracked deal is $77.0M Series B in Crossbow Therapeutics in March 2026.
